Literature DB >> 11840336

c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene.

T I Kuschak1, B C Kuschak, C L Taylor, J A Wright, F Wiener, S Mai.   

Abstract

The mechanisms through which the oncoprotein c-Myc initiates locus-specific gene amplification are not understood. When analysing the initiation mechanism of c-Myc-dependent amplification of the mouse ribonucleotide reductase R2 (R2) gene, we observe c-Myc-dependent initiation of illegitimate DNA replication of the R2 gene. We demonstrate multiple simultaneous c-Myc-induced R2 replication forks, whereas R2 normally replicates with a single fork. In contrast, cyclin C replicates with only a single replication fork irrespective of c-Myc deregulation. In addition to de novo replication forks, c-Myc also initiates bi-allelic replication of R2, abrogating its normal mono-allelic replication pattern. Moreover, several chromosomal regions also display c-Myc-induced illegitimate replication profiles. Thus, c-Myc can act as an illegitimate replication-licensing factor that promotes de novo replication initiation and illegitimate replication timing that adversely impacts upon genomic stability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11840336     DOI: 10.1038/sj.onc.1205145

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus.

Authors:  Sherif F Louis; Bart J Vermolen; Yuval Garini; Ian T Young; Amanda Guffei; Zelda Lichtensztejn; Fabien Kuttler; Tony C Y Chuang; Sharareh Moshir; Virginie Mougey; Alice Y C Chuang; Paul Donald Kerr; Thierry Fest; Petra Boukamp; Sabine Mai
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-27       Impact factor: 11.205

Review 2.  Global regulation of genome duplication in eukaryotes: an overview from the epifluorescence microscope.

Authors:  John Herrick; Aaron Bensimon
Journal:  Chromosoma       Date:  2008-01-16       Impact factor: 4.316

Review 3.  c-MYC-induced genomic instability.

Authors:  Alexandra Kuzyk; Sabine Mai
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

4.  c-Myc-induced extrachromosomal elements carry active chromatin.

Authors:  Greg Smith; Cheryl Taylor-Kashton; Len Dushnicky; Stephen Symons; Jim Wright; Sabine Mai
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

Review 5.  MYC Oncogene Contributions to Release of Cell Cycle Brakes.

Authors:  Lucía García-Gutiérrez; María Dolores Delgado; Javier León
Journal:  Genes (Basel)       Date:  2019-03-22       Impact factor: 4.096

6.  CCT244747 is a novel potent and selective CHK1 inhibitor with oral efficacy alone and in combination with genotoxic anticancer drugs.

Authors:  Mike I Walton; Paul D Eve; Angela Hayes; Melanie R Valenti; Alexis K De Haven Brandon; Gary Box; Albert Hallsworth; Elizabeth L Smith; Kathy J Boxall; Michael Lainchbury; Thomas P Matthews; Yann Jamin; Simon P Robinson; G Wynne Aherne; John C Reader; Louis Chesler; Florence I Raynaud; Suzanne A Eccles; Ian Collins; Michelle D Garrett
Journal:  Clin Cancer Res       Date:  2012-08-28       Impact factor: 12.531

7.  Differential processing of let-7a precursors influences RRM2 expression and chemosensitivity in pancreatic cancer: role of LIN-28 and SET oncoprotein.

Authors:  Yangzom Doma Bhutia; Sau Wai Hung; Madeline Krentz; Dimal Patel; Dylan Lovin; Radhika Manoharan; J Michael Thomson; Rajgopal Govindarajan
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

Review 8.  MYC-Induced Replicative Stress: A Double-Edged Sword for Cancer Development and Treatment.

Authors:  Laura Curti; Stefano Campaner
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.